Screener
Vor Biopharma VOR EBIT
EBIT at other companies
Other financials
Where this comes from
Calculated from Vor Biopharma’s reported figures.
The source filing: Vor Biopharma’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 8:31 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-220689
FAQ
- What is Vor Biopharma's EBIT?
- Vor Biopharma (VOR) reported EBIT of -$35.16M in Q1 2026.
- How has Vor Biopharma's EBIT changed year-over-year?
- Vor Biopharma's EBIT decreased by 5.6% year-over-year, from -$33.29M to -$35.16M.
- What is the long-term trend for Vor Biopharma's EBIT?
- Over 4 years (2021 to 2025), Vor Biopharma's EBIT has grown at a 52.3% compound annual growth rate (CAGR), from -$69.02M to -$371.64M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Vor Biopharma's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude